ADMA Biologics

US · ADMA #2705 by market cap Listed 1970

10.14 -0.04 -0.39%

Live - 5344 symbols - heartbeat 30s ago · 2026-10-08 06:48

Pre-market 9.94 -1.98%

After-hours 10.14 0.00%

Market cap: 2.27B
P/E (TTM): 14.49
P/B: 5.57
EPS: 0.60
Div yield: 0.00%
52W pos: 22%

Reader sentiment Are you bullish or bearish on ADMA?

Anonymous reader poll. Unscientific, not investment advice.

About ADMA Biologics

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Founded: 2004
CEO: Mr. Adam S. Grossman
Employees: 647
Headquarters: Ramsey, New Jersey, United States of America
Fiscal year end: 12-31
Website: admabiologics.com

Company profile

Exchange: US
Symbol: ADMA
Market-cap rank: #2705
Listing date: 1970-01-01
Market cap: 2.27B
Float cap: 2.23B
Shares out: 223.98M
Float shares: 219.66M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 06:48:57 · For reference only, not investment advice and not tailored to your situation.